Time to re-think the olanzapine dose

Alex Molassiotis

Research output: Journal article publication › Comment/debate/erratum

ASJC Scopus subject areas

@article{013705d79ac643ed8620a0a0246fc9c3,

title = "Time to re-think the olanzapine dose",

author = "Alex Molassiotis",

year = "2020",

month = feb,

doi = "10.1016/S1470-2045(19)30791-0",

language = "English",

volume = "21",

pages = "189--190",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Time to re-think the olanzapine dose

AU - Molassiotis, Alex

PY - 2020/2

Y1 - 2020/2

UR - http://www.scopus.com/inward/record.url?scp=85078449588&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30791-0

DO - 10.1016/S1470-2045(19)30791-0

M3 - Comment/debate/erratum

C2 - 31838012

AN - SCOPUS:85078449588

SN - 1470-2045

VL - 21

SP - 189

EP - 190

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 2

ER -